Showing 841 - 860 results of 107,546 for search '(( a de decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 841
  2. 842
  3. 843

    Increased CDK13 complexes expression decreases PNC prevalence. by Yasmine Even (1888192)

    Published 2016
    “…SiRNA2 only faintly diminished CDK13 expression levels and did not significantly altered PNC prevalence. In contrast, siRNA5 strongly altered CDK13 expression, leading to a significant decrease in PNC prevalence. …”
  4. 844
  5. 845
  6. 846
  7. 847
  8. 848
  9. 849
  10. 850
  11. 851
  12. 852
  13. 853
  14. 854

    Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

    Published 2011
    “…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
  15. 855
  16. 856

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  17. 857
  18. 858
  19. 859
  20. 860

    NAC prevents VMH GI neuron activation by decreased glucose. by Xavier Fioramonti (371172)

    Published 2013
    “…(B) Percentage of VMH GI neurons from S<sup>3</sup>S or I<sup>3</sup>S rats pre-treated or not with NAC which depolarized in response to a 2.5–0.7 mM glucose decrease quantified using changes in FLIPR-MPD fluorescence intensity. *: p<0.05 (Two-way ANOVA; group differences were determined by One-Way ANOVA followed by Bonferoni post-hoc test).…”